NASDAQ: SABSRUSSELL2000
SAB Biotherapeutics, Inc.
Healthcare · Biotechnology · Headquartered in Miami Beach, US
Price
Loading chart…
Overview
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of SAB Biotherapeutics, Inc., its business model, key products, and controversies.